Dr. Sara Hurvitz is the Director, Breast Cancer Clinical Trial Program at UCLA Medical Center and Associate Professor of Medicine at the David Geffen School of Medicine at UCLA. She is also the Director of Jonsson Comprehensive Cancer Center Clinical Research Unit. Dr. Hurvitz received her MD from the University of Southern California School of Medicine and then completed her internal medicine residency at UCLA, serving as chief resident, followed by her hematology/oncology fellowship at UCLA.
Dr. Hurvitz specializes in breast cancer treatment, and is involved in designing, implementing and leading national and international clinical trials to test new targeted therapies for breast cancer. She is board-certified in internal medicine and medical oncology and has received numerous awards, including the Marni Levine Memorial Breast Cancer Research Award in years between 2008 and 2015. She currently leads the Translation Oncology Research Laboratory at UCLA in the preclinical evaluation of novel breast cancer targets.
Dr. Hurvitz is also a member of the American Society of Clinical Oncology and the American Association of Cancer Research, and is a fellow of the American College of Physicians.